A multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the safety and efficacy of repeat treatment with two dose levels of Botox (botulinum toxin type A) purified neurotoxin complex followed by a treatment with Botox in patients with urinary incontinence due to neurogenic detrusor overactivity
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 23 Jan 2007
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Urge incontinence
- Focus Therapeutic Use
- 23 Jan 2007 New trial record.